Free Trial

Direxion Daily S&P Biotech Bull 3x Shares Rating

Direxion Daily S&P Biotech Bull 3x Shares logo
$114.40 +1.29 (+1.14%)
Closing price 10/23/2025 04:10 PM Eastern
Extended Trading
$115.50 +1.10 (+0.96%)
As of 07:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

LABU Aggregate Rating

Moderate Buy
2.67

Holdings in LABU have an aggregate rating of Moderate Buy based on 290 analyst ratings issued in the past year covering 14 companies (12.6% of the portfolio).

LABU Aggregate Price Target

$114.40
High Prediction$114.40
Average Prediction$114.40
Low Prediction$114.40

Holdings in LABU have an aggregate price target of $114.40 and a range of $114.40 to $114.40 covering 14 companies (12.6% of the portfolio).

LABU Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
Moderate Buy
10 Moderate Buy rating(s)
Hold
3 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 14 LABU Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
1.07%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$67.21
+1.0%
2.4795 of 5 stars
2.42$72.59 8.0%19Gap Up
0.93%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$71.50
3.2067 of 5 stars
2.80$78.50 9.8%20
0.91%
Moderna, Inc. stock logo
MRNA
Moderna
$26.25
-2.2%
4.2522 of 5 stars
2.00$36.86 40.4%21Trending News
Analyst Forecast
Gap Down
0.91%
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
$64.85
+3.1%
4.4086 of 5 stars
2.92$69.90 7.8%24Analyst Forecast
0.91%
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$53.44
+0.9%
4.3124 of 5 stars
3.00$77.50 45.0%16Analyst Forecast
0.91%
Insmed, Inc. stock logo
INSM
Insmed
$160.12
-0.2%
3.0622 of 5 stars
2.86$152.88 -4.5%21Positive News
Upcoming Earnings
0.89%
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
$426.21
+1.1%
4.7377 of 5 stars
2.57$461.62 8.3%14Positive News
Upcoming Earnings
Insider Trade
0.88%
AbbVie Inc. stock logo
ABBV
AbbVie
$228.74
+0.0%
4.631 of 5 stars
2.74$234.80 2.6%27Trending News
Upcoming Earnings
Analyst Revision
0.87%
Amgen Inc. stock logo
AMGN
Amgen
$292.89
-1.0%
4.5474 of 5 stars
2.28$300.94 2.7%18Positive News
0.87%
Natera, Inc. stock logo
NTRA
Natera
$195.00
+3.7%
1.8868 of 5 stars
2.80$197.59 1.3%20Trending News
Analyst Forecast
Insider Trade
Short Interest ↑
0.86%
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
$48.55
+3.6%
2.658 of 5 stars
2.95$67.78 39.6%19
0.86%
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$422.63
-0.9%
4.8044 of 5 stars
2.62$494.38 17.0%29Positive News
0.85%
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$53.81
+1.1%
4.5525 of 5 stars
2.88$65.25 21.3%17Analyst Forecast
0.85%
Exelixis, Inc. stock logo
EXEL
Exelixis
$38.05
+5.5%
4.7842 of 5 stars
2.64$44.53 17.0%25Trending News
Analyst Upgrade
Analyst Revision

This page (NYSEARCA:LABU) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners